ACTO raises $11.5 million to bolster life sciences sales with AI

ACTO, a startup using AI-powered mobile experiences to educate stakeholders in life sciences, today closed an $11.5 million funding round. The round dovetails with the launch of the company's capabilities for supporting doctors, nurses, and other health providers with conversational AI that surfaces information about drugs and medical devices. "Pharma and medtech companies are answering the call of duty during the pandemic," ACTO CEO Parth Khanna told VentureBeat via email. "Now more than ever, we need to bring medical innovations to market quickly and efficiently. With the new funding, ACTO is well-positioned to help life sciences pioneers thrive in the'new normal' and accelerate digital transformation to virtually engage all key stakeholders, from reps to providers to patients."